MapLight Therapeutics

MapLight Therapeutics

MA - Burlington
Biotechnology

Focus: Optogenetics

MapLight Therapeutics is a life sciences company focused on Optogenetics.

Rare Diseases
Funding Stage
SERIES C +
Open Jobs
10

Pipeline & Clinical Trials

Clinical Trials (1)
NCT05889273ML-004 Open-Label Extension Study in Adults and Adolescents With Autism Spectrum Disorders (ASD)
Phase 2
Phase 2
Clinical Trials (1)
NCT07038876A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With Schizophrenia
Phase 2
Clinical Trials (1)
NCT05081245ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)
Phase 2
Clinical Trials (1)
NCT06887192A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2

Open Jobs (10)

Interview Prep Quick Facts
Portfolio: 6 clinical trials
Top TAs: Neurology
Open Roles: 10 active jobs
Therapeutic Area Focus
Neurology
4 pipeline
Marketed
Pipeline

Hiring Trend

Stable
10
Open Roles
+0
Added
-0
Filled/Removed

Based on last 4 crawl cycles